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Purpose of this study is to evaluate the success rates of secondary alveolar grafts using recombinant 
human bone morphogenetic protein with CBCT and to evaluate the effects of several variables on 
these outcomes. After our inclusion/exclusion criteria, records of 24 patients receiving secondary 
alveolar grafts at the University of Nebraska Medical Center were evaluated. Pre-graft and 6-month 
post-graft cleft volumes were measured using ITK-SNAP 3.8.0 software to determine a percent 
residual defect following surgery. Of the 24 patients, one was excluded as the graft surgery was 
deemed a failure. The patients’ gender, age, side of cleft, cleft side canine root lengths, angulations, 
and distance from the occlusal plane were also measured. The mean volumetric values for the pre-
graft and post-graft clefts were 1049.30mm3 and 413.75mm3, respectively with a mean residual 
defect value of 0.32 (SD = 0.22). The difference in percent residual defect following the graft was 
not statistically significant for any of the variables measured, except for gender (F=10.63; DF=1,21; 
p=0.0037). This study showed females undergoing secondary grafts of unilateral alveolar clefts 
have a lower percent residual defect six months following surgery. However, the results of this 
study may not represent clinical outcomes and larger sample sizes may be helpful to conclude 
statistically significant differences between our variables.
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CHAPTER 1: INTRODUCTION 
Birth defects are always a concern for parents and may cause lifelong setbacks, especially 
in the early part of the child’s life. In the United States, 7,500 children are born every year with 
orofacial clefts, and the lifetime medical cost per child with orofacial clefts is significant, 
averaging $100,000 (Tolarová and Cervenka 1998). Worldwide, cleft lip and palate are among 
the most common birth defects that occur. These can occur as isolated conditions or they can be a 
component of a syndrome or inherited disease. The prevalence of cleft palate is 1 per 1,574 live 
births. The prevalence of cleft lip, with or without cleft palate, is 1 per 940 live births (Parker et 
al. 2010). Within this group of patients born with cleft lip and palate, approximately 75% have 
maxillary alveolar clefts (Bell et al. 1980).    
According to Kang, an alveolar cleft is “a tornado-shaped bone defect in the maxillary 
arch” (2017). Alveolar clefts cause a disruption to the normal continuous bony environment in the 
maxillary arch. This can lead to multiple factors that affect the child and child’s parents 
including: early feeding difficulties, nutritional issues, developmental delays, speech difficulties, 
facial asymmetry, hearing loss, discomfort during and/or following surgical procedures, time 
commitments, the need for orthodontic care, and possibly psychosocial issues for the child and/or 
child’s parents (Coots 2012). 
Bone grafting of alveolar clefts has become an essential component in the contemporary 
management of patients with orofacial clefts. Secondary alveolar bone grafting has been shown to 
improve some of the factors listed above as well as allow for successful orthodontic treatment and 
implant or prosthetic rehabilitation (Cho-Lee et al. 2013). 
Up until about the past 10 years, anterior iliac crest (AIC) autogenic bone has been 
considered the gold standard grafting material for alveolar clefts. AIC’s regeneration potential 
and high success rates make it a viable option for these children (Kazemi et al. 2002). However, 
there are several shortcomings with using iliac crest including: significant post-operative 
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morbidity, hematomas, pain, delayed ambulation, and prolonged hospitalization (Baqain et al. 
2009). To overcome these shortcomings, there have been attempts to find a viable replacement 
material to use in secondary alveolar grafts.  Recombinant human bone morphogenetic protein 2 
(rhBMP-2) was approved by the Food and Drug Administration for maxillary sinus augmentation 
in 2004 and ridge augmentation following dental extractions in 2007.  This material has since 
been shown to be a successful alternative when reconstructing an alveolar cleft (Francis et al. 
2013; van Hout et al. 2011). 
The proper timing for reconstructing alveolar clefts is still slightly controversial. 
Secondary alveolar bone grafting, undertaken late in mixed dentition before eruption of the 
canine, is currently considered the standard treatment (Francis et al. 2013). There are also a 
number of other variables that are believed to influence the outcome of alveolar bone grafts 
including: chronological age of the patient at the time of the graft, stage of root development for 
the cleft side canine at the time of the graft, the surgeon who performed the graft, and unilateral 
versus bilateral clefts (Francis et al. 2013; Oberoi et al. 2009; Seifeldin 2016). The way in which 
we view several of these variables has changed over time.   
Occlusal and periapical radiographs have been used to evaluate bone fill within these 
alveolar clefts and to map segmentally the height, thickness, and position of bone on the roots 
adjacent to the cleft. Hammoudeh et al. reported the results of comparing rhBMP-2 with a 
demineralized bone matrix versus iliac crest bone for secondary alveolar bone graft using 
occlusal radiographs (2017).  There are obvious shortcomings in attempting to determine the 
outcomes of alveolar bone grafts from 2-dimensional images. With the advent of 3-demensional 
imaging systems such as cone beam computed tomography (CBCT), a more accurate analysis can 
be performed when studying alveolar bone graft outcomes. Thus, CBCT has become the new 
standard for analyzing bone fill of alveolar clefts. 
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 The rationale for this project is that its successful completion would help to determine 
the effects of several variables on the proper timing of secondary alveolar graft procedures and on 
the success rates for these procedures. CBCT analysis of maxillary alveolar clefts allow for 
assessing the bone defect in three dimensions, a shortcoming of previous conventional 
radiographic studies. This research is potentially innovative because our specific variables and 
their effects on unilateral alveolar cleft grafting success rates have yet to be explored with 3-
dimensional software in regards to these treatment differences. The primary impact of our 
anticipated findings would be determining the overall success rates of secondary alveolar grafting 
procedures using rhBMP-2 as an alternative material and understanding specific variables that 
may allow craniofacial and cleft teams to better manage patients with orofacial clefts. 
The purpose of this study is to evaluate the success rates of secondary alveolar grafts 
using rhBMP-2 as a grafting material with 3-dimensional CBCT as well as to evaluate the effects 
of several variables on these outcomes. 
 The null hypothesis is there will be no difference in secondary alveolar graft success 
rates when comparing our specific variables and their effects on these outcomes using 3-

















Figure 1.1.: Unilateral Alveolar Cleft.  Example of a unilateral alveolar cleft is shown.  A) 
Diagram showing a unilateral (left) alveolar cleft with tissue intact. B) A mucoperiosteal flap has 
been reflected to show the underlying bone defect and unerupted upper left permanent canine.  Note 
that this unerupted canine has 2/3’s of its root developed. Graphics by K. Theesen. Additional credit 
to Dias et al. 2018. 
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CHAPTER 2: LITERATURE REVIEW 
2.1. Cleft Lip and Cleft Palate 
 2.1.1. Etiology 
 Development of cleft lip and cleft palate (CLCP) happens early in embryologic 
development. Between the fourth and eighth week of embryologic life, the embryo undergoes 
rapid changes in shape and growth as the six branchial arches are formed. The first two branchial 
arches are responsible for the development of the face and the cranium. The face begins to 
develop from the ectomesenchyme, derived from neural crest cells, which forms five 
prominences.  These prominences include the frontonasal process and two maxillary and two 
mandibular processes (one of each per side) surrounding a central depression (Sperber et al. 
2001). 
 The primary and secondary palates are derived from the medial nasal and maxillary 
processes and are two of the main structures involved with the formation of orofacial clefts. Rani 
et al. defines the primary palate as comprising the premaxilla, anterior septum, and upper lip. The 
roof of the mouth extends from the incisive foramen or its vestige, the incisive papilla, to the 
uvula.  This area is termed the secondary palate. The incisive foramen is the dividing line 
between the primary and secondary palates (2011). 
 Clefting of the lip occurs in response to a failure of fusion between the medial nasal 
process, which is an extension of the frontonasal process, and the maxillary prominence.  The 
fusion of these prominences normally occurs during the sixth week of embryologic development. 
The normal fusion of these structures during primary palate formation creates not only the upper 
lip but also the area of the alveolar ridge containing the central and lateral incisors. Since there is 
a disruption in the normal development of this area, a cleft in the alveolar process will often 
accompany a cleft lip (Proffit et al. 2013). 
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 Clefting of the palate occurs in response to a slightly different abnormality. Closure of 
the secondary palate by elevation of the palatal shelves follows the formation of the primary 
palate by nearly two weeks; around the eighth week of embryologic life. There is a disruption in 
this normal fusion of the palatal shelves, which leads to a palatal cleft. An interference with 
normal lip closure that is still present at this time can also affect the proper development of the 
secondary palate.  About 60% of subjects with cleft lip also have cleft palate (Proffit et al. 2013).  
Additionally, 75% of individuals born with cleft lip and palate have maxillary alveolar clefts 
(Bell et al. 1980). 
 Normal embryologic development (Figure 2.1.1) of other facial structures is also a result 
of proper fusion of prominences derived from the first two branchial arches.  For example, the 
mandibular processes fuse to form the lower lip and jaw and the lateral nasal processes form the 
alar structure of the nose bilaterally (Sperber et al. 2001). 
 2.1.2. Biological Considerations 
 As the neural crest cells migrate and proliferate to their respective branchial arches, they 
interact with extracellular matrix and adjacent epithelia, which partly determines the patterning 
and nature of the derivative tissues they will form. These include neural, skeletal, connective, and 
muscular tissues (Sarkar et al. 2001). 
 The development of facial structures is the result of cell proliferation, differentiation, 
adhesion, and apoptosis. The facial prominences of the neural crest cells are controlled by 
molecular signals. These signals are a result of interactions and responses to genes that include 
the transforming growth factor beta (TGF-b) super family, sonic hedgehog (SHH), fibroblast 
growth factors (FGFs), and bone morphogenic proteins (BMPs). Orofacial clefts are a result of 
failures or errors in any of these intracellular mechanisms that disrupt the normal fusion or 
development of facial prominences (Marazita and Mooney 2004). 
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 In addition to the genes listed previously, there are a number of other genes that have 
been linked to orofacial cleft development. The homeobox (Hoxa-1, Hoxa-2, Hoxb-1, Hoxb-3, 
Hoxb-4), OXT (orthodontical), GSC (goosecoid), DLX (distalless), and MSX (muscle segment) 
gene families have also been expressed in the ectomesenchyme derived from the neural crest. 
Many of these genes are candidates for causing orofacial clefting (Sperber et al. 2001). 
 There are also environmental factors that contribute to the development of orofacial 
clefts. These factors can be divided into four groups: drugs, chemicals, maternal metabolic 
imbalances (folic acid deficiency), and maternal infections. Maternal consumption of alcohol and 
teratogenic medications such as retinoids, corticosteroids, and anti-convulsants during the 
periconceptional period can cause facial abnormalities including orofacial clefts (Eppley et al. 
2005). Genetic mutations and environmental impacts upon the complex mechanisms of 
craniofacial development lead to phenotypic anomalies, of which orofacial clefting is the most 
common (Schutte and Murray 1999). 
 Many mechanisms underlying normal and abnormal embryogenesis of the craniofacial 
structures are well understood. The genetic factors that cause abnormal development and result in 
orofacial clefts are not completely clear, however much progress has been accomplished over the 
years. The emerging consensus is that the genetic etiology of nonsyndromic clefting is complex, 
with several loci showing drastic results in at least some studies. In addition, genes or 
chromosomal rearrangements on many chromosomes can lead to syndromes that include 
orofacial clefts (Marazita and Mooney 2004). 
 2.1.3. Associated Syndromes 
 As we have learned, orofacial clefts can have an environmental or genetic origin 
depending on how the abnormality was caused. Although the nonsyndromic clefts are more 
common and likely due to secondary gene-environment interactions, orofacial clefts can occur as 
one component of multiple congenital anomaly syndromes (Schutte and Murray 1999). 
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 Every structural abnormality in the body that is congenital represents an embryologic 
error in morphogenesis and may affect one or more systems (Venkatesh 2009). There are 
currently over 400 known syndromes either directly or indirectly associated with cleft lip and/or 
cleft palate. It has been estimated that approximately three percent of all orofacial cleft cases are 
related to known syndromes (Fraser 1970). 
   Van der Woude syndrome is one of the most common syndromes associated with 
orofacial clefts. This syndrome is autosomal dominant and can display several other features 
including: hypodontia, missing maxillary or mandibular second premolar teeth, absent maxillary 
lateral incisor, ankyloglosia, and the hallmark feature of lower lip pits (Venkatesh 2009). 
 Another autosomal dominant disorder that is associated with orofacial clefts is Treacher 
Collins syndrome. This syndrome results from the loss-of-function mutation in the TCOF-1 gene. 
This gene encodes for the phosphoprotein “treacle” and can affect craniofacial development. 
Treacher Collins syndrome affects the size and shape of the ears, cheekbones, and jaw. Some of 
the key features include: downslanting eyes, underdeveloped cheek and jaw bones, notched lower 
eyelids, and cleft palate (Dixon et al. 2000). 
 Pierre Robin sequence is another congenital condition that is associated with cleft lip 
and/or cleft palate. In 1926, Pierre Robin published a case with a triad of glossoptosis, 
micrognathia, and airway obstruction. Although cleft palate was not included in this triad, they 
are frequently associated with this sequence. The most accepted theory involves the initial event 
of mandibular hypoplasia, which keeps the tongue elevated in the oral cavity. This prevents 
fusion of the palatal shelves resulting in cleft palate (Venkatesh 2009). 
 Velocardiofacial syndrome is another autosomal dominant condition that is associated 
with orofacial clefts. This syndrome is a result of a sub-microscopic deletion on the long arm of 
chromosome 22 in the “q11” region. It was first described by Dr. Robert Shprintzen and affects 
every major system in the body. Some of the more common features include: cleft palate, minor 
learning problems, speech issues, feeding problems, and cardiac anomalies (Venkatesh 2009) 
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 Stickler syndrome is a connective tissue disorder that is also associated with cleft palate. 
It is also an autosomal dominant disorder with ophthalmological and orofacial features. Stickler 
syndrome is a result of a mutation in the COL2A1 gene and children with this condition can 
display midline clefting ranging in severity from a cleft of the soft palate to complete cleft lip and 
palate. Other features of this syndrome include: a flat midface with depressed nasal bridge, short 
nose, anteverted nares, and micrognathia (Snead and Yates 1999). 
 Understanding the etiology of orofacial clefts is vital for proper prevention, treatment, 
and management. Appropriate genetic testing, diagnosis, and treatment planning of orofacial 
clefts by a craniofacial cleft lip/cleft palate team can provide comfort to the patient and patient’s 
parents. This can also lead to proper management and give the team the highest chance for a 
successful treatment outcome. 
 2.1.4 Classification 
 There are about one hundred different combinations of cleft lip and cleft palate. Having a 
system in place to properly diagnose the clefts and determine a severity assessment helps in the 
planning of an appropriate treatment method. An ideal system would be easy to understand, easy 
to locate and to quantify the cleft lesion, easy to document, easily applicable to computerized data 
analysis, and should be applicable for both clinical applications and research (Rani and 
Chickmagalur 2011). 
 Classification of cleft lip and cleft palate deformities has been through multiple changes 
over the years, each with a different basis for classifying these orofacial clefts, ranging from 
anatomic and embryologic considerations to the complexity of the deformity. Davis and Ritchie 
developed one of the first classification systems in 1922, which was used for years, despite its 
shortcomings. To date, the Kernahan and Stark’s classification system and Kernahan’s modified 




 Although classifying cleft lip and cleft palate has cycled through systems relating to the 
morphological and embryological backgrounds, schemes for classifying cleft lip and/or cleft 
palate are usually anatomically based. These classifications may include complete or incomplete, 
unilateral or bilateral, a submucous cleft, and/or bifid uvula (Seifeldin 2016).  
 2.1.5. Prevalence 
Cleft lip and/or cleft palate is the most prevalent congenital craniofacial birth defect. The 
incidence ratio for cleft lip and/or cleft palate has been reported to be approximately 1:700 live 
births (Cobourne 2004). Additionally, cleft lip and/or cleft palate is the second most common 
congenital malformation following clubfoot (Miloro et al. 2004). The occurrence of cleft palate is 
6.35 per 10,000 live births. The occurrence of cleft lip, with or without cleft palate, is 10.63 per 
10,000 live births (Parker et al. 2010). Within this group of patients born with cleft lip and palate, 
approximately 75% have maxillary alveolar clefts (Bell et al. 1980). 
Unilateral cleft lip and palate is more common than bilateral. Cleft lip and palate is more 
common on the left side than on the right side. When cleft palate is analyzed alone, it is more 
common in females and most often associated with other developmental anomalies (Seifeldin 
2016).  However, if analyzing cleft lip, alveolus, and palate, males are more often affected than 
females (van Hout et al. 2011). 
The incidence of these clefts (alveolus, palate, and lip) also varies between different 
races. Mongolians have an incidence of 0.55-2.5 per 1,000 births. Caucasians have an incidence 
of 0.69-2.35 per 1,000 births. And finally, Negroids have an incidence of 0.18-0.82 per 1,000 





2.2. Alveolar Cleft 
The term alveolus is of Latin origin and refers to a small cavity (Coots 2012). The 
alveolus is a part of the primary palate and is formed by the fusion of the maxillary prominences 
approximately at the fifth and sixth weeks of intrauterine development. The primary palate gives 
rise to structures including: nose, lip, prolabium, and the premaxilla; all of which are anterior to 
the incisive foramen (van Aalst et al. 2008). The incisive foramen has been determined to be the 
dividing structure differentiating the primary and secondary palates. 
The alveolar processes, found in both the maxilla and mandible, are where the tooth 
sockets are located. These alveolar processes, and the bone that makes them up, are connected to 
the teeth via periodontal ligaments. In individuals with alveolar clefts, the individual’s permanent 
teeth, which are above the alveolar cleft, are not sustainable if there is not adequate bone stock 
placed in the alveolar cleft into which they can erupt. The permanent maxillary canine tooth 
typically erupts into the alveolar cleft space or becomes impacted. The permanent maxillary 
lateral incisor tooth erupts either adjacent to the alveolar cleft or into the cleft (Coots 2012).  
According to Kang, an alveolar cleft is “a tornado-shaped bone defect in the maxillary 
arch.” Alveolar clefts occur in response to divergence from normal intrauterine development 
during frontonasal prominence growth, contact, and fusion. Although maxillary alveolar clefts 
can occur mesial to either the lateral incisor or canine, the most common location is between the 
lateral incisor and canine (2017). These three dimensional defects are pyramidal in shape (Figure 
2.2.1) with the following boundaries: nasal floor superiorly, posterior alveolus (palate) inferiorly, 
anterior alveolus anteriorly, and medial/lateral cleft margins determining the medial and lateral 
borders (Craven et al. 2007). 
Alveolar clefts cause a disruption in the continuity of the maxillary arch. This can lead to: 
early feeding difficulties, nutritional issues, developmental delays, speech difficulties, facial 
asymmetry, hearing loss, discomfort during and/or following surgical procedures, time 
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commitments, delayed or ectopic eruption patterns, the need for orthodontic care, and possibly 
psychosocial issues for the child and/or child’s parents (Coots 2012). 
2.3. Managing Alveolar Clefts 
 2.3.1. History 
 Reconstruction of alveolar cleft is believed to be introduced by von Eiselsberg in the 
early 20th century. He used autologous tissue to assist with the reconstruction process. Lexer was 
the first to describe a nonvascular bone graft. Drachter reported the repair of an alveolar cleft 
using the tibial bone as a grafting material, while Schmid was the first to utilize this procedure for 
implanting iliac bone grafts into the defect. Skoog developed a boneless bone graft technique 
known as gingivoperiosteoplasty (Kang 2017). 
Up until the 1970’s, “primary bone grafting” was completed while the individual with 
alveolar cleft was an infant. This was accomplished with rib bone and was the popular surgical 
procedure used to manage alveolar clefts (Kang 2017). Primary bone grafting involves 
reconstruction of the alveolar cleft in association with soft tissue repair to the cleft lip. This 
technique gained popularity because it simultaneously addressed both soft tissue and bony deficit 
repair. It also was thought this technique would allow for harmonious facial growth and 
development following the procedure (Seifeldin 2016).  
However, there were shortcomings associated with primary alveolar bone grafting. 
Robertson and Rherm reported adverse developmental effects on maxillary development. 
Individuals who had primary bone grafting were seen to have midface retrusion and/or anterior 
cross bites (Dissaux et al. 2016). This led to the currently accepted approach of “secondary bone 
grafting.”  
Secondary bone grafting is the most recognized surgical approach for managing alveolar 
defects in cleft lip/cleft palate individuals. It is believed that the shortcomings associated with 
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primary bone grafts are not as serious of a concern when the procedure is completed later in 
development (Kang 2017). 
2.3.2. Goals 
 Every individual born with a cleft lip and/or cleft palate should be assessed and evaluated 
carefully. The individual’s breathing and signs of airway obstruction, ability to feed, nutritional 
intake, weight gain, growth, syndromic associations that require genetic testing, and craniofacial 
anomalies need to be evaluated. Additionally, it is important to evaluate the severity and type of 
defect, the width of the defect, position of alveolar segments and premaxilla, nasal deformity, the 
need for presurgical orthopedics, type of appliance necessary, and prepare the child and parents 
for surgical repair of cleft (Bagheri et al. 2011). For this reason, it is vital for individuals with 
clefts to be managed by a specialized craniofacial and cleft lip/cleft palate team. 
 There are several primary goals when managing the alveolar cleft. The goals of a 
successful alveolar graft include: creating a continuous maxillary arch, facilitating eruption of 
permanent teeth, providing adequate bone support, preserving periodontal health of teeth adjacent 
to the cleft, permitting orthodontic tooth alignment, allowing placement of osseointegrated 
implants, and improving alar base symmetry. In addition, it is important to contemplate the 
effects of surgery and timing of this procedure on continued midface development (Bergland et 
al. 1986; Amanat and Langdon, 1991; Cohen et al. 1993; Dempf et al. 2002; Oberoi et al. 2009; 
Francis et al. 2013; Linderup et al. 2016; Seifeldin, 2015; Hammoudeh et al. 2017; Fahradyan et 
al. 2019).   
2.3.3. Treatment Timing 
Historically, alveolar bone grafts have been completed at three different time periods 
relative to teeth development: at the time of deciduous dentition, at the time of mixed dentition, 
and following mixed dentition. Primary bone grafting is performed in the deciduous stage of 
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dental development, secondary bone grafting is performed during the mixed dentition, and 
tertiary bone grafting is performed following the mixed dentition (Fahradyan et al. 2019). 
Primary bone grafting has been shown to have poor results causing orofacial teams to 
abandon the technique. To overcome the skeletal, occlusal, and periodontal problems of the 
ungrafted cleft, secondary bone grafting has become the technique/surgery of choice. This 
technique was popularized by Abyholm et al. (1981), but Boyne and Sands (1972) receive a lot of 
the credit for the scientific and biological basis of the technique. Secondary bone grafting of the 
alveolar cleft is ideally completed before the eruption of and when two-thirds of the root has 
developed on the cleft side canine tooth. This typically ranges from 7-12 years of age, but the 
dental age of the patient is a more accurate way to analyze proper treatment timing compared to 
chronological age (Amanat and Langdon 1991). 
The current standard of deciding on an appropriate treatment time is based on the 
radiographic analysis of the cleft side canine root development; however, this method is also 
controversial.    
2.3.4. Outcomes and Success Rates 
 Defining a “successful” unilateral alveolar graft may have different meanings for 
different specialists. To an oral surgeon, a successful alveolar graft may mean any stability of the 
grafting material at the post-graft observation. To an orthodontist, a successful alveolar graft may 
mean the improved ability for the canine to erupt normally and enhanced ability to align teeth 
within the continuous osseous ridge. Previous studies address success rates for alveolar cleft 
grafts as either percent bone fill or percent residual cleft defect following the procedure. These 
methods are becoming the new standard to avoid the difficult identification process in 
differentiating natural alveolar bone from graft material on CBCT images. 
Herford et al. used computed tomography to compare bone morphogenetic protein-
induced repair of the premaxillary cleft with the gold standard anterior iliac crest as a graft 
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material. This study analyzed 12 total subjects. The average age of patients receiving anterior 
iliac crest graft was ten and the average age of patients receiving bone morphogenetic protein 
graft was eight. Their post-graft images were captured at 4-months following the surgery and they 
concluded an average bone fill of 78.1% and 71.7% for anterior iliac crest and bone 
morphogenetic protein respectively (Herford et al. 2007). 
Another study analyzed the percentage of bone fill 1-year post-graft using anterior iliac 
crest. There were 21 subjects in this study and the average age at the time of alveolar bone 
grafting was 10 years 7 months +/- 2 years 8 months. CBCT images were used for measuring the 
volumetric values of the alveolar cleft. The authors concluded an 84.1% bone fill for unilateral 
alveolar cleft patients with a range of 61.9% to 96.5% (Oberoi et al. 2009). 
Francis et al. used occlusal radiographs to compare recombinant human bone 
morphogenetic protein-2 with autologous iliac crest bone for repairing alveolar clefts. This study 
analyzed 55 consecutive patients with an average age of 11.8 years. Their post-graft images were 
captured at an average of 21 months following surgery. The authors defined a successful alveolar 
graft as, “those with radiographically evident bony bridging at the cleft site for which no 
subsequent regrafting procedure was necessary.” They used the Bergland and Chelsea scale to 
evaluate the occlusal radiographs. This study concluded a 94.4% success rate for rhBMP-2 and an 
84.2% success rate for anterior iliac crest (Francis et al. 2013). 
Dickinson et al. studied older alveolar cleft patients to see if there was reduced morbidity 
and improved healing when using bone morphogenetic protein-2 as a graft material. The average 
age at surgery was 16.4 +/- 1.5 years and 15.9 +/-1.9 years for the bone morphogenetic protein-2 
and anterior iliac crest groups respectively. Panoramic and computed tomography images were 
captured pre-graft and 1-year post-graft to determine the results. As far as morbidity, the authors 
concluded bone morphogenetic protein-2 to be superior to anterior iliac crest in the following 
areas: donor site pain, length of hospital stay, and overall cost of the procedure. As far as bone 
healing, this study concluded bone morphogenetic protein-2 to have a larger percentage alveolar 
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defect fill (95%) compared to anterior iliac crest (63%) at the 1-year post-graft scan (Dickinson et 
al. 2008). 
A paper from 2016 analyzed a different grafting material to be used during secondary 
alveolar graft procedures. Linderup et al. used mandibular symphyseal bone and CBCT images to 
analyze the success rates of alveolar cleft grafting procedures at 1-year post-graft. 32 total 
patients were studied with an average age of 9 years 6 months. The authors concluded an 87% 
bone fill ratio with a range of 47% to 100% post-graft (Linderup et al. 2016). 
Hammoudeh et al. conducted a study using occlusal radiographs to compare alveolar 
bone graft success rates using human bone morphogenetic protein-2 and iliac crest bone for graft 
materials. The authors defined a successful graft as one that did not require additional surgeries to 
repair the defect. Functionally, graft success was evaluated based on the cleft side canine eruption 
pattern. If this canine was able to erupt naturally on its own, the graft was deemed a functional 
success. This study concluded success rate of alveolar grafts at 88.4% and 90.0% for iliac crest 
bone and human bone morphogenetic protein-2 respectively (Hammoudeh et al. 2017). 
Finally, in 2011 a systematic review was completed on the results of using bone 
morphogenetic protein-2 for alveolar graft procedures. The use of this tissue engineered graft 
material has shown favorable results. This study concludes that the use of bone morphogenetic 
protein-2 has good results in terms of quantity of bone formation within the cleft, shortens the 
operation time, eliminates the donor site morbidity issue, shortens the hospital stay, and reduces 
the overall cost (van Hout et al. 2011). 
 In addition to overall success rates for secondary alveolar grafts, a number of factors are 
believed to influence the outcome of alveolar bone grafting. Independent variables have 
previously been analyzed to determine their effects on these outcomes. According to previous 
studies, there is no significant difference between unilateral and bilateral cleft patients in terms of 
success rates. The size of the preoperative alveolar cleft did not appear to influence the success 
rates. There was also no significant difference in outcomes when comparing if an adjacent lateral 
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incisor was present or not. The developmental stage of the cleft side canine did not statistically 
show an effect on the outcomes. And finally, there was no difference in outcomes when 
comparing gender differences (Linderup et al. 2016; Oberoi et al. 2009).             
2.4. Materials Used for Secondary Alveolar Grafts 
 Grafting orofacial clefts dates back to the early twentieth century. In 1901, Von 
Eiselsberg was the first surgeon to use autogenous bone to graft the maxillary cleft by way of a 
free bone sample of the little finger. Lexer was also on the forefront of these methods in 1908. In 
1914, Drachter was the first to report the successful closure of a cleft with tibial bone and 
periosteum (Lilja 2009). Since these first methods were introduced, various graft materials, 
including tibia, calvarium, mandible, rib, and anterior iliac crest have been analyzed and 
compared (Linderup et al. 2016). The hope is to find an alveolar cleft graft material that will 
allow for the elimination of donor site morbidity, prolonged hospital stays, increased surgical 
cost, and post-graft pain while delivering high success rates and allowing for proper physiological 
and psychological function of the maxillofacial complex. 
 Cortical and cancellous bones can be used for grafting orofacial clefts, but cancellous 
bone seems better due to the cell transfer and revascularization noticed in osteoinduction and 
osteoconduction. Fresh autologous cancellous bone has been reported to be the most ideal bone 
graft source because of the increased amount of osteogenic precursor cells within the matrix 
(Kang 2017; Seifeldin 2016). Cortical bone takes longer to incorporate at the graft site because it 
relies on vascular ingrowth in a process called “creeping substitution.” In addition to being better 
in osteoinduction and osteoconduction processes, cancellous bone has also been shown to allow 
tooth eruption more often (Coots 2012). Numerous autologous bone donor sites have been used 




  Bosker and van Dijk were the first to report the use of mandibular symphysis bone as a 
grafting material for secondary alveolar grafts in 1980. The mandible has the same embryonic 
origin as the maxilla and because it is an intramembranous bone, revascularization is fast and 
resorption is minimal (Kang 2017; Seifeldin 2016). This material seemed attractive because it 
displayed low morbidity while allowing for satisfactory success rates. Some of the advantages 
include: restriction to one intraoral operation site, shorter time in the hospital, minimal 
discomfort, and an incision located in the lower labial sulcus leading to an invisible scar. 
Disadvantages associated with mandibular symphysis include: limited volume of bone available 
for grafting bilateral clefts, a small operation site eliminates the possibility of two operative teams 
working at the same time, increased amount of cortical bone in the donor material, and possible 
injury to the mental nerve that could result in changes in sensitivity of adjacent teeth/soft tissues 
(Coots 2012; Linderup et al. 2016; Rawashdeh and Telfah 2008). 
As stated previously, Drachter was the first to use tibial bone to reconstruct alveolar 
clefts in 1914. Since then, few authors have reported the tibia as a donor site for alveolar grafts. 
The tibia has been extensively used in orthopedic surgeries and is a popular material among 
maxillofacial surgeons, however most of the procedures completed with tibia material is seen in 
adult patients, and mainly for trauma incidences. Some of the advantages of using tibia as a graft 
material include: shorter operation time, minimal scarring, shorter hospital stay, and quicker 
ambulation. On the contrary, the disadvantages of using the tibia as a graft material seem to far 
outweigh the advantages. These include: lack of available material in younger patients, close 
proximity to the growing epiphyseal cartilage, possibly needing to take material from both legs, 
proximal tibial fractures (reported in the range of 0-2.7%), and the need to avoid contact sports 
for at least three months (Kang 2017; Rawashdeh and Telfah 2008; Seifeldin 2016). 
 Another graft material that has been studied is calvarial bone. This material has shown 
similar success rates for alveolar grafts when compared to iliac crest bone. Some of the 
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advantages for using calvarial bone include: inconspicuous scar formation, lack of functional 
deformity, appropriate surgical field, and volume of bone that can be harvested. However, there 
are high risk disadvantages that go along with this material and complication rates range from 
0.25-5.5%. These include: long operative time, wound infection, minimal cancellous bone, thin 
bone, and intracranial complications such as hematoma, dural tear, dural exposure, and 
cerebrospinal fluid leakage. Calvarial bone is most often suggested for patients who do not have a 
high chance of multiple head injuries such as athletes (Kang 2017; Rawashdeh and Telfah 2008; 
Seifeldin 2016). 
 Autogenous bone taken from the anterior iliac crest is considered the most common 
method and optimal material for grafting alveolar clefts and is thus termed the “gold standard 
bone graft.” It has also been shown that this material should be the standardized graft to which 
other types of alveolar bone grafts should be compared. Some advantages of using anterior iliac 
crest include: provides a large quantity of cancellous bone, has easy surgical access, great 
osteogenic potential with abundant pluripotent osteogenic precursor cells. The disadvantages 
associated with using iliac crest for grafting alveolar clefts include: hematoma, pain, delayed 
ambulation, prolonged hospital stay, possible scaring, and risk of cutaneous nerve injury (Kang 
2017; Rawashdeh and Telfah 2008; Seifeldin 2016). To help reduce these complications, limited 
incision, reduced musculature elevation, hemostasis, adequate pain control, and quick ambulation 
are suggested (Kang 2017). 
 To eliminate the donor site morbidity and other complication with autogenous bone 
grafts, tissue engineering has become a popular concept for developing an alternative to the 
previously studied graft materials used for secondary alveolar grafting procedures. Three vital 
components are necessary for tissue engineering and include: bone-forming cells, osteoinductive 
growth hormone, and an osteoconductive scaffold. The scaffold provides mechanical support, 
mimics the bony matrix, and guides the formation of bone in the defect area. This scaffold can 
serve as a carrier for the osteoinductive growth hormone. This hormone is thus delivered locally 
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and ideally over a sustained period of time to recruit mesenchymal stem cells to differentiate into 
osteogenic cells (van Hout et al. 2011). 
 With these novel methods of producing and delivering graft material alternatives, many 
of these materials have been studied and their success rates have been analyzed. One of the most 
commonly used substitutes for secondary alveolar grafts is recombinant human bone 
morphogenetic protein-2 (rhBMP-2). rhBMP-2 was initially identified by Marshall Urist, an 
orthopedic surgeon conducting research on bone mineralization, and Strates in the 1960’s. These 
proteins are involved in the natural formation and development of the human skeleton. Very 
small quantities are contained in the mature skeleton and are associated with bone maintenance 
and fracture repair. Early on, Urist placed demineralized, lyophilized segments of allogeneic bone 
matrix into muscle pockets in rabbits and watched as bone was formed. This led him to postulate 
the concept that these proteins, located within the matrix, can promote the formation of 
osteoblasts (Chin et al. 2005). 
rhBMP-2 belongs to the transforming growth factor-superfamily of proteins. This 
protein induces bone and cartilage formation through signal pathways (Hammoudeh et al. 2017). 
They are essential for skeletogenesis in the embryo and for bone remodeling throughout life. 
Supraphysiologic levels of these proteins promote de novo bone generation (Francis et al. 2013).  
Bone morphogenetic proteins (BMPs) in general were approved by the United States 
Food and Drug Administration (FDA) for maxillary sinus augmentation in 2004 and alveolar 
ridge augmentation following dental extraction in 2007. Although rhBMP-2 has been shown to 
have favorable outcomes as an alternative grafting material, it has been considered to be off-label 
for the use of grafting alveolar clefts (Francis et al. 2013; van Hout et al. 2011). Despite the 
approval for augmentation procedures, rhBMP-2 has raised concerns over its use for grafting 
orofacial clefts. An initial U.S Food and Drug Administration warning was issued after accounts 
of post-graft dysphagia and airway compromise due to swelling in patients who received it 
around the cervical spine. Another U.S FDA warning was issued in 2015 for safety issues arising 
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with the use of rhBMP-2 in the pediatric population out of concern for insufficient data to 
represent long-term safety and efficacy (Hammoudeh et al. 2017). However, in recent years 
several groups and research teams have reported experiences using rhBMP-2 off-label for 
alveolar cleft reconstruction in the pediatric population (Francis et al. 2013). 
A study conducted at the Children’s Hospital Los Angeles prior to the U.S. FDA warning 
on rhBMP-2 compared the outcomes of using rhBMP-2 vs iliac crest as a grafting material for 
alveolar clefts in the pediatric population. A demineralized bone matrix was used as the carrying 
scaffold during the procedures. During a 10-year period, this study did not observe an increase in 
evidence of infection, heterotopic ossification, malignant transformation, or airway compromise 
for the patients receiving rhBMP-2 (Hammoudeh et al. 2017). This study was a pivotal point in 
the introduction of rhBMP-2 as an attractive alternative to the previous gold standard, iliac crest, 
for secondary grafting of alveolar clefts in younger patients.  rhBMP-2 has also been shown to 
display improved bone healing and decreased post-graft pain in adult patients receiving alveolar 
cleft grafts when compared to iliac crest (Dickinson et al. 2008). 
Overall, rhBMP-2 appears to be an attractive alternative graft material to the previous 
gold standard, iliac crest. It would allow for the elimination of donor site morbidity, decrease the 
post-graft pain, reduce the overall cost of the procedure, limit hospital stay, and promote post-
graft ambulation while still allowing for high success rates for alveolar graft procedures.   
2.5. Cone Beam Computed Tomography to Evaluate Alveolar Graft Procedures 
 Up until recently, the majority of secondary alveolar graft studies have been conducted 
using two-dimensional radiographs, such as occlusal, panoramic, and periapical films. These 
studies have used these images, along with either the Bergland scale (Figure 2.5.1) or Chelsea 
scale (Figure 2.5.2), to evaluate the alveolar cleft defect area and to understand the outcomes of 
secondary alveolar grafts (Trindade et al. 2005). In the Bergland scale system, a four-point 
system was used to classify each graft depending on the coronal level of the interdental bone 
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compared to normal levels. One of the main shortcomings with this system was that the graft was 
compared only at the interdental level using normal bone levels for reference values (Seifeldin 
2016).   
There are obvious shortcomings in attempting to determine the outcomes of alveolar bone 
grafts from 2-dimensional images. They do not accurately quantify the 3-dimensional pyramidal 
shape of the alveolar cleft of interest and could initiate errors when determining the true defect 
volume. Computed tomography (CT) was one of the first radiographic techniques used to 3-
dimensionally view the alveolar cleft entirely. Because traditional CT images had high radiation 
doses, long scan times, and low quality/low resolution images, other radiographic methods were 
discovered. Between 1998 and 1999, cone-beam (CB) systems were introduced for oral and 
maxillofacial images and replaced the traditional CT images allowing for limited radiation doses 
(approximately 15-times less), minimal scanning time (10-70 seconds), and high 
quality/resolution images (Seifeldin 2016). Over the last decade, the orthodontic and dental field, 
as a whole, has adopted the use of CBCT for diagnosis, treatment planning, and reduction of 
radiation dose compared to conventional tomography (Ludlow et al. 2015). 
Various 3-dimensional software have been reported and used in the identification, 
segmentation, and quantification of orofacial and alveolar clefts. Software such as Amira 3.1.1, 
Mimics 15.0; Materialise Interactive Medical Image Control System, and ITK-SNAP 3.8.0 have 
been reported throughout the orthodontic literature in regards to determining/measuring 
volumetric values of alveolar clefts. 







CHAPTER 3: RESEARCH HYPOTHESIS & SPECIFIC AIMS 
3.1. Statement of the Problem 
 Bone grafting of alveolar clefts is an essential component in the contemporary 
management of patients with orofacial clefts. The search for an appropriate alternative to the 
autogenous graft material, such as anterior iliac crest, has included experiments with many 
substitutes. However, alveolar bone graft outcomes of rhBMP-2, as an alternative to autogenous 
sources, in unilateral alveolar cleft patients is yet to be studied. Determining the appropriate 
timing for this procedure to produce the best outcome is also still controversial. Chronological 
age, root development of the cleft side canine, and stage of dental maturity have all been used to 
estimate the most appropriate time to graft the alveolar cleft. Additionally, there may be other 
factors that need to be analyzed to determine the proper timing of alveolar bone graft procedures 
and to better estimate the success rates of these grafts.  
 Intraoral occlusal and periapical radiographs have been used to evaluate bone fill within 
an alveolar cleft and to map segmentally the height, thickness, and position of bone adjacent to 
the roots of the cleft. With the shortcomings associated with analyzing a three dimensional 
structure using two dimensional radiographs, the use of three-dimensional CBCT radiography has 
become a popular alternative. CBCT imaging would allow one to better appreciate the severity, 
location, and overall graft outcome of unilateral alveolar clefts. Since this technology is readily 
available and reliable, it could be utilized to investigate the clefts pre-graft as well as post-graft to 
determine the overall success rates. This knowledge is essential to be able to foresee what 
variables affect the graft outcomes. This information can be used to aid practitioners in 
understanding the severity of the orofacial cleft, treatment planning the alveolar graft procedure, 




3.2. Central Research Hypothesis 
 The central research hypothesis is that there will be a difference in secondary alveolar 
graft success rates when comparing: gender, age, side of the cleft, canine root development, 
canine angulation in both the coronal and sagittal planes, and canine distance from the occlusal 
plane and their effects on these outcomes using 3-dimensional software for analysis. 
3.3. Specific Aims 
 1) To determine the overall success rate of using rhBMP-2 for unilateral secondary 
alveolar cleft grafts using CBCT radiography. 
 2) To determine if gender, age, side of the cleft, canine root development, canine 
angulation in both the coronal and sagittal planes, or canine distance from the occlusal plane have 















CHAPTER 4: MATERIALS & METHODS 
4.1. Study Design 
 This study is a retrospective comparison of pretreatment and post-treatment CBCT 
images of patients with unilateral alveolar clefts who received secondary alveolar bone grafts at 
the University of Nebraska Medical Center Oral and Maxillofacial Surgery Center in Omaha, 
Nebraska. This study protocol was reviewed and approved by the University of Nebraska Medical 
Center Institutional Review Board (#113-20-EP) and the Boys Town National Research Hospital 
Institutional Review Board (#20-03-X).   
4.1.1. Data Collection 
It is routine for patients with cleft lip and palate to see a craniofacial and cleft lip/cleft 
palate team for proper management. The team at Boys Town National Research Hospital consists 
of a wide range of specialists including: pediatrician, orthodontist, oral surgeon, plastic surgeon, 
otolaryngologist, speech pathologist, audiologist, craniofacial nurse, genetic counselor, social 
worker, and a nutritionist. Dr. V.D. is the oral surgeon on this Boys Town National Research 
Hospital team. He routinely collects a pre-graft CBCT radiograph for the orofacial cleft patients 
requiring alveolar cleft grafting procedures. The information from this image is used to diagnose 
problems, create treatment objectives, and formulate a comprehensive treatment plan. 
Additionally, Dr. V.D. routinely captures a 6-month post-graft CBCT radiograph to monitor the 
success rates and analyze the graft material uptake/residual defect. 
Consecutive patients with unilateral alveolar clefts who received secondary alveolar bone 
grafts from Dr. V.D., from June 1, 2014 to January 1, 2020, were selected for this study. 
Inclusion criteria for this study included: patient age between 7-13 years old at the time of the 
alveolar graft surgery, patients with unilateral alveolar cleft, patients who used rhBMP-2 as the 
graft material, and access to available pre-graft and post-graft CBCT images. Exclusion criteria 
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included patients who received an alveolar bone graft previously, patients who have had a failed 
bone graft, those with bilateral alveolar clefts, and patients who received anterior iliac crest bone 
graft. 24 patients were included in this study and their pre-graft and post-graft CBCT images were 
analyzed. 
CBCT images were acquired using a Kodak 9500 3D scanner (Kodak Dental Systems, 
Carestream Health, Rochester, NY). The orofacial cleft was captured with the following settings: 
tube potential of 90kV, current of 10mA, 3.6 second exposure time, 0.2mm scanning layer 
thickness, and 200um voxel size. All data sets with DICOM (Digital Imaging and 
Communications in Medicine) format were transferred to Invivo5 (version 5.2; Anatomage 
Dental, San Jose, California) for storage and interpretation. 
The DICOM data were exported and scanned to university protected disks at the 
University of Nebraska Medical Center Oral and Maxillofacial Surgery Center. All data was 
uploaded to the University of Nebraska Medical Center protected database to ensure patient 
confidentiality. DICOM data were imported to Precision Workstation T3600 desktop computer 
(Dell, Round Rock, TX) with appropriate imaging software as described in subsequent sections. 
All images were viewed on a 60.47 cm LED widescreen display monitor screen (Dell) having a 
resolution of 1920 x 1080 pixels. 
 Demographic and treatment variables were recorded for each patient based on the 
information obtained from the patients’ charts. Age of the patient at the time of surgery, graft 
material used during the procedure, side of the unilateral cleft, and gender of the patient were 
documented for analysis. 
4.1.2. Surgical Technique 
All grafting procedures were performed under general anesthesia with orotracheal 
intubation. Patients received preoperative prophylactic antibiotic therapy of cefazolin or 
clindamycin, if allergic to cefazolin. A one surgeon team completed the unilateral grafts using 
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rhBMP-2 (INFUSE, Medtronic; Memphis, Tennessee). The same surgeon, Dr. V.D., performed 
all the procedures to help standardize the case results. Deciduous and supernumerary teeth in the 
direct vicinity of the unilateral alveolar cleft were extracted one to three months prior to the 
surgery. This was completed to aid in grafting outcomes and facilitate mucosal flap design 
utilizing increased keratinized epithelium. 
 The surgical procedure for grafting of unilateral alveolar clefts was followed as described 
by Boyne and Sands (Boyne and Sands 1972) with and without the modification of strut 
technique described by Stoelinga et al. (Stoelinga et al. 1990). Several other modifications were 
used during these surgical procedures including: the use of 4-0 Vicryl to close the nasal mucosa, 
the use of 3-0 and 4-0 Vicryl to close the oral mucosal flaps, and the application of cyanoacrylate 
to the reconstructed nasal floor and oral mucosal tissues after closure. 
 For grafting these unilateral alveolar cleft patients, 0.7cc to 1.4cc (1.05mg to 2.10mg) 
rhBMP-2 with acellular collagen sponge carrier was used. An allogeneic demineralized human 
cortical bone strut (OsteoWrap, Bacterin; Belgrade, Montana) was also used during the 
procedure. 
 Postoperatively, all patients were treated with five days of cephalexin or clindamycin, 
advised to have a soft diet for one month, and no strenuous activity recommended for two weeks.  
4.2. Linear Measurements 
Root lengths of the maxillary canines were measured in millimeters to the nearest 
hundredth decimal value with specific attention given to the canine on the side of the alveolar 
cleft. These lengths were measured on CBCT images within the open source segmentation ITK-
SNAP 3.8.0 software. Measurements were taken at the following time points: pre-graft and 6-
month post-graft. Two separate linear measurements were taken from the cementoenamel 
junction (CEJ) to the apex of the tooth in the CBCT layer/slice representing the direct long axis of 
the canine tooth (Figure 4.2.1). The method for measuring root length was based on methods in 
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previous studies. The canine root lengths were compared to average mature maxillary canine root 
length values reported to determine the percentage of canine root development at the time of 
alveolar grafting. The average mature maxillary canine root lengths used as references were 15.83 
+/- 1.49mm and 15.23 +/- 1.78mm for males and females respectively (Kim et al. 2013). 
CBCT images were analyzed using ITK-SNAP 3.8.0 in both the coronal and sagittal 
sections to determine the angulation of the cleft side maxillary canine tooth in relation to a true 
perpendicular reference line. These values were measured in degrees and recorded to the nearest 
tenth decimal value. In the coronal section, a reference line was traced on the true vertical 
crosshair. Then, a second line was traced through the long axis of the cleft side canine passing 
through the apex of the tooth (Figure 4.2.2). These angular measurements were recorded for both 
the pre-graft and post-graft time periods with attention given to the pre-graft values.    
Additionally, the angulation of the cleft side maxillary canine tooth was measured in the 
sagittal section. In this view, a reference line was traced on the true horizontal crosshair. A 
second line was traced through the long axis of the cleft side canine passing through the apex of 
the tooth (Figure 4.2.3). These values were recorded for both the pre-graft and post-graft time 
periods with attention given to the pre-graft values. 
The final linear measurement measured was the distance of the cleft side canine tooth to 
the defined occlusal plane. This was measured in millimeters to the nearest hundredth decimal. 
Using the ITK-SNAP 3.8.0 software, the CBCT images were viewed in the sagittal section. A 
reference line was created from the most inferior aspect of the mesial cusps on the permanent first 
molar to the most inferior portion of the central incisor on the alveolar cleft side (through all 
layers/slices). This reference line was defined as the occlusal plane in this study for all patients. 
Next, a line was inserted from the most inferior tip of the cleft side canine tooth to the defined 
occlusal plane reference line. These two lines always formed a 90-degree angle at their 
intersection. These values were recorded for both the pre-graft and post-graft time periods with 
attention given to the pre-graft values.  
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Two investigators (L.P. and S.P.) each independently completed the root length 
measurements on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these same 10 
patients (20 CBCT scans) were analyzed by the same two investigators independently. These 
measurements were used to determine the intra-examiner and inter-examiner reliability of the 
method used. Once the reliability of the method was established, each investigator completed the 
root length measurements for one-half of the total sample number. 
The cleft side canine angulation measurements and distance from the occlusal plane 
measurement were performed by investigator L.P. Again, these three measurements were initially 
completed on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these same 10 patients 
(20 CBCT scans) were analyzed by the same investigator. These measurements were used to 
determine the intra-examiner reliability of the method.  
4.3. Volumetric Measurements 
The unilateral maxillary alveolar cleft volumes were determined from the pre-graft and 6-
month post-graft CBCT images using the open source segmentation software ITK-SNAP 3.8.0. 
These volumes were measured in cubic millimeters to the nearest hundredth decimal.  
The first step in segmentation was using the semi-automatic, or “active contour 
segmentation mode (5)”, feature in ITK-SNAP 3.8.0. A large region of interest was set in the 
axial, coronal, and sagittal planes to encompass the desired alveolar cleft defect as well as a large 
portion of the maxillary arch and adjacent teeth (Figure 4.3.1). The “Active Label” was changed 
to a green color, representing bone and/or hard tissue. The pre-segmentation mode was used to 
adjust the contrast and instruct the software algorithm to separate bone/teeth voxels from soft 
tissue voxels. Within the inverted image, the upper threshold limit was increased to the maximum 
to limit variability between pretreatment and post-treatment images. The lower threshold limit 
was chosen by the investigator, for each CBCT image, based on adequate bone to soft tissue 
differentiation. The smoothness parameter was also set to the maximum value to help standardize 
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the results and limit inaccurate segmentation (Figure 4.3.2). The initialization mode allowed the 
investigator to place pre-set bubbles to communicate areas of interest to the software (Figure 
4.3.3). Other parameters used during the auto-segmentation feature were setting the step size to 2 
and allowing the iteration to run until 600 and 1000 for pre-graft and post-graft CBCT images 
respectively. Automatic segmentation was allowed to proceed until the raw segmentation began 
to involve adjacent structures (Figure 4.3.4). 
Once the bone and/or hard tissues were segmented out, the polygon mode (3) was used 
for manual segmentation of the alveolar cleft defect. The feature allows for segmentation in the 
three orthogonal slices. The “Active Label” was changed to a red color, representing soft tissue, 
and the segmentation could be painted in any “clear labels” within the ITK-SNAP software 
(Figure 4.3.5). The polygon mode tool was used to trace out the defect through all slices included 
in the region of interest that was set based on previous papers. The protocol for setting up the 
region of interest was adopted from and very similar to that of Linderup (Linderup et al. 2015). 
The boundaries for the region of interest can be seen in Table 4.3.1. The superior boundary was 
determined to be ten slices inferior to the anterior nasal spine (ANS); confirmed on the coronal 
section as a radiopaque dot. The inferior boundary was determined to be the most apical portion 
of the palatal CEJ of the adjacent tooth. The anterior and posterior boundaries were determined 
by the anatomical structure of the contralateral alveolar ridge within the slice being analyzed. The 
medial and lateral boundaries were determined by the initial auto-segmentation process of 
labeling the bone and/or hard tissues.    
Two investigators performed the volumetric measurements of the unilateral alveolar cleft 
defects. Both investigators were calibrated to eliminate any bias or structural identification errors 
during manual segmentation. These calibrations were used to minimize the human error presented 
in the potential artistic interpretation. After the final segmentation was achieved for the region of 
interest (Figure 4.3.6), the volumetric value was recorded from the “volumes and statistics” tab in 
ITK-SNAP 3.8.0. (Figure 4.3.7). 
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Two investigators (L.P. and S.P.) each independently completed the unilateral alveolar 
cleft volume measurements on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these 
same 10 patients (20 CBCT scans) were analyzed by the same two researchers independently. 
These measurements were used to determine the intra-examiner and inter-examiner reliability of 
the method used. Once the reliability of the method was established, each researcher completed 
the volumetric measurements for one-half of the total sample number. 
4.4. Statistical Analysis 
All data were entered into Excel (version 2016; Microsoft, Redmond, Wash). The PROC 
GLIMMIX procedure in SAS 9.4 (SAS Institute; Cary, NC) was used to analyze the percent 
residual defect in relation to the explanatory variables of interest. Residual and quantile-quantile 
plots (QQ-plots) were used to asses model fit. A generalized linear model following a beta 
distribution with a logit link was used to account for the underlying distribution of the percent 
residual defect. When differences occurred, least significant difference (LSD) was reported at the 
 = 0.05 level. A total sample size of 24 subjects was analyzed for the volumetric and linear 
measurements.   
To assess the reliability of the methods used in this study, duplicate measurements were 
taken on ten consecutive patients at least two weeks apart. Intra-class correlation coefficients 
(ICCs) were calculated for intra-examiner and inter-examiner reliability using R version 3.6.3 (R 
Core Team; Vienna, Austria). ICC3 values were used when all subjects are rated by the same 
raters who are assumed to be the entire population of raters. These values are reported because we 
are interested in how investigators (LP and SP) are rating the measurements and do not care to 





4.5. Intra-examiner and Inter-examiner Reliability 
Intra-examiner reliability was measured with intra-class correlation coefficients (ICCs) 
using R version 3.6.3 (R Core Team; Vienna, Austria). It was determined by repeating the 
volumetric and cleft side canine root length linear measurements on ten patients by the original 
investigator (LP or SP) at least two weeks after the initial measurements on pre-graft and post-
graft CBCT images. Intra-examiner reliability was also measured for the cleft side canine 
angulation and distance from the occlusal plane linear measurements. These were measured by 
investigator (LP) on ten patients. At least two weeks later, these measurements were repeated on 
the same ten patients by the same investigator (LP) for the pre-graft and post-graft CBCT images.  
Inter-examiner reliability was determined by comparing the volumetric and cleft side 
canine root length linear measurements on ten patients for pre-graft and post-graft CBCT images 
using R version 3.6.3 (R Core Team; Vienna, Austria).  The inter-examiner reliability was 
determined on the same ten patients selected for the intra-examiner reliability test. Again, the 














Figure 2.1.1: Normal Embryologic Facial Development. Five prominences are shown during 
the second (left), fifth (middle), and eighth (right) week of embryologic development. These 
prominences normally fuse with each other as well as other prominences to develop anatomical 
structures. Disturbances in normal fusion of any of these prominences can lead to congenital 















Figure 2.1.4: Kernahan Striped “Y” Classification System. To date, this is one of the most 
commonly used systems for classifying orofacial clefts. Depending on the anatomical location 
or extent of the cleft, a numerical value is given to the orofacial cleft. The incisive foramen (red 
text above) is used as a boundary point between the primary palate (#3 & #6) and hard palate 














Figure 2.2.1: Alveolar Cleft Shape. Classic pyramidal shape of an alveolar cleft. The medial 
and lateral boundaries are determined by the extent of the cleft (red and purple text above). 
The superior boundary is determined by the nasal floor (blue text) and the inferior boundary is 
determined by the palate/posterior alveolus (orange text). The anterior boundary is determined 





Figure 2.5.1: Bergland Scale. This scale evaluates the amount of bone produced in the cleft 
site based on the height of the intraalveolar septum on 2-dimensional images. Heights are 
measured in between the adjacent teeth with a superior and inferior border. The superior 
border is defined by a line between the tips of the roots of the adjacent teeth. The inferior 
border is defined by the cementoenamel junction coronally. 1: normal height 2: less than 
normal height by greater than 75 percent of normal bone height 3: less than 75 percent of 







Figure 2.5.2: Chelsea Scale. This scale evaluates and quantifies the amount of ossification 
within the alveolar cleft site. Bone fill of 100 percent in the alveolar cleft defect is represented 
by a score of 8 (left). Partial scores of 0.5 can be used and are counted for sectors that have 
partial bone fill but lack bony bridging across the alveolar cleft site (right). Additional credit 














Figure 4.2.1: Cleft Side Canine Root Length Measurement. Sagittal view of an immature 
canine on the side of the unilateral alveolar cleft. Two separate linear measurements were taken 
from the cementoenamel junction (CEJ) to the level of the apex in the CBCT layer/slice most 
accurately representing the direct long axis of the canine tooth. This was usually determined in 
the coronal or sagittal (shown above) views within the ITK-SNAP 3.8.0 software. The two 
values were averaged and the mean value was recorded for comparison to previously reported 









Figure 4.2.2: Cleft Side Canine Angulation; Coronal Section. Coronal view of the cleft side 
canine within ITK-SNAP 3.8.0. The first line (red) was made on the true vertical crosshair 
approximately located at the midline. The second line (also red) was traced down the long axis 
of the cleft side canine tooth. The software automatically calculated the angle formed between 








Figure 4.2.3: Cleft Side Canine Angulation; Sagittal Section. Sagittal view of the cleft side 
canine within ITK-SNAP 3.8.0. The first line (red) was made on the true horizontal crosshair. 
The second line (also red) was traced down the long axis of the cleft side canine tooth. The 
software automatically calculated the angle formed between these two lines and this value was 


















Figure 4.3.1: Region of Interest for Semi-automatic Mode. Axial view of the region of 
interest for the semi-automatic mode within ITK-SNAP 3.8.0. It has been set in the axial, 
sagittal, and coronal planes. This region (red dotted lines above) includes the unilateral 















Figure 4.3.2: Active Contour Evolution Parameters in ITK-SNAP 3.8.0. Within ITK-SNAP 
3.8.0, the upper limit and smoothness parameters were set to the maximum values. The lower 
limit was chosen by the investigator, for each CBCT image, based on adequate bone to soft tissue 
differentiation (250 in the image above). These parameters were set in each CBCT scan to help 













Figure 4.3.3: Pre-set Bubbles in the Initialization Mode. The contrasted views above show 
hard tissue (white) and soft tissue (blue) within the initialization mode of ITK-SNAP 3.8.0. 
Green was selected as the “active label” for bone and/or hard tissues. Bubbles were manually 

















Figure 4.3.4: Auto-segmentation of Bone and/or Hard Tissues. Axial, sagittal, and coronal 
views of the segmented-out bone and/or hard tissues (green). This is the stage after auto-
segmentation has been completed in ITK-SNAP 3.8.0. Note the medial and lateral boundaries 















Figure 4.3.5: Polygon Mode; Manual Segmentation of the Cleft. Within ITK-SNAP 3.8.0., 
the unilateral alveolar cleft was manually segmented on the axial view. The superior most 
boundary was determined by ten slices inferior to ANS and the inferior most boundary was 
determined by the palatal portion of the CEJ on the adjacent incisor tooth. Through these slices, 
the anterior and posterior boundaries of the cleft were determined from the anatomical 
structures of the contralateral side. The software filled in the defect in all three planes shown 














Table 4.3.1: Region of Interest Boundaries for Manual Segmentation. Definitions of the 
region of interest boundaries used during the manual segmentation process within ITK-SNAP 













Figure 4.3.6: Final Volumetric Segmentation Image in ITK-SNAP 3.8.0. Example of a left 
side unilateral alveolar cleft segmented in ITK-SNAP 3.8.0. software for final analysis. Green: 
bone and/or hard tissues Red: soft tissues representing the alveolar cleft defect. Note the 






















Figure 4.3.7: Final Volumetric Measurement in ITK-SNAP 3.8.0. “Volumes and Statistics” 
tab within ITK-SNAP 3.8.0. Green: bone and/or hard tissue volume segmented Red: soft tissue 





CHAPTER 5: RESULTS 
5.1. Subjects 
The records of all the patients who have received secondary alveolar bone grafts at the 
University of Nebraska Medical Center Oral and Maxillofacial Surgery Center from June 1, 2014 
to January 1, 2020 were retrieved. Twenty four patients were included in this study after 
application of the exclusion and inclusion criteria and their pre-graft and 6-month post-graft 
CBCT scans were analyzed. Of the 24 patients, one was excluded as the graft surgery was 
deemed a failure. Data collected from 23 patients were submitted for statistical analysis. The 
average age of the patients in this study was 10 years 3 months (range = 8-13 years; SD = 1 year 
6 months). Of the 23 patients included, 12 were female and 11 were male. There were 13 left-
sided unilateral alveolar clefts and 10 right-sided unilateral alveolar clefts.  
5.2. Demographic Variables and Their Effects on Outcomes 
 5.2.1. Gender 
 The effect of gender on the alveolar bone graft outcomes was evaluated. Figure 5.2.1.1 
displays the raw percent residual defect reported for male and female patients. When analyzing 
percent residual defect using a generalized linear model (GLM) following a beta distribution with 
a logit link function, Table 5.2.1.1 shows that there is a statistically significant difference in the 
true mean percent residual defect between males and females (F=10.63; DF=1,21; p=0.0037). 
 The least square means for the mean percent residual defect by male and female can be 
viewed in Table 5.2.1.2. The estimated mean percent residual defect for females is 20.52% 
(Standard Error = 4.2%) and we are 95% confident the true mean percent residual defect for 
females is between 13.1% and 30.68%. The estimated mean percent residual defect for males is 
44.20% (Standard Error = 5.7%) and we are 95% confident the true mean percent residual defect 
50 
 
for males is between 32.93% and 56.1%. This information can also be reported and visualized in 
a plot with error bars indicting the 95% confidence interval (Figure 5.2.1.2). 
 5.2.2. Age of the Patient at the Time of Grafting 
 Age of the patient at the time of grafting was evaluated to determine if it had an effect on 
alveolar bone graft outcomes. Figure 5.2.2.1 displays the raw percent residual defect reported for 
age of patient at the time of grafting. When analyzing percent residual defect using a GLM 
following a beta distribution with a logit link function, Table 5.2.2.1 shows that there is no 
statistically significant relationship between the percent residual defect and the age of the patient 
at the time of grafting (F=0.00; DF=1,21; p=0.97). 
 The regression coefficient estimates for the intercept, age of the patient at the time of 
grafting, and residual variance (scale) can be viewed in Table 5.2.2.2. Note that these estimates 
are on the model scale (non-normal data distribution) and will not have a direct interpretation 
other than direction of the slope. For percent residual defect and age of the patient at the time of 
grafting, the estimated slope is negative with a value of -0.00466 (standard error = 0.1297). 
 5.2.3. Side of the Alveolar Cleft 
 The effect of side of the alveolar cleft on the alveolar bone graft outcomes was evaluated. 
Figure 5.2.3.1 displays the raw percent residual defect reported for left and right side alveolar 
clefts. When analyzing percent residual defect using a GLM following a beta distribution with a 
logit link function, Table 5.2.3.1 shows that there is no statistically significant difference in the 
true mean percent residual defect between left and right side alveolar clefts (F=0.6; DF=1,21; 
p=0.45). 
 The least square means for the mean percent residual defect by left and right side alveolar 
clefts can be viewed in Table 5.2.3.2. The estimated mean percent residual defect for the left side 
alveolar cleft is 34.46% (Standard Error = 5.7%) and we are 95% confident the true mean percent 
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residual defect for left side alveolar cleft is between 23.67% and 47.12%. The estimated mean 
percent residual defect for the right side alveolar cleft is 28.06% (Standard Error = 6.0%) and we 
are 95% confident the true mean percent residual defect for right side alveolar cleft is between 
17.31% and 42.08%. This information can also be reported and visualized in a plot with error 
bars indicting the 95% confidence interval (Figure 5.2.3.2). 
5.3. Linear Values and Their Effects on Outcomes 
 5.3.1. Cleft Side Canine Root Length 
Root length of the canine on the alveolar cleft side was measured to determine if it had an 
effect on the outcome of the alveolar bone grafts. The lengths were compared to previously 
reported mature maxillary canine root length values and analyzed as a percent. Figure 5.3.1.1 
displays the raw percent residual defect reported for the cleft side canine root length percent. 
When analyzing percent residual defect using a GLM following a beta distribution with a logit 
link function, Table 5.3.1.1 shows that there is no statistically significant relationship between the 
percent residual defect and cleft side canine root length percent (F=0.61; DF=1,21; p=0.44). 
 The regression coefficient estimates for the intercept, cleft side canine root length 
percent, and residual variance (scale) can be viewed in Table 5.3.1.2. Note that these estimates 
are on the model scale (non-normal data distribution) and will not have a direct interpretation 
other than direction of the slope. For residual defect and percent root length of the canine on the 
cleft side, the estimated slope is negative with a value of -0.9491 (standard error = 1.22). 
5.3.2. Cleft Side Canine Angulation; Coronal Section 
Angulation, in the coronal section, of the canine on the alveolar cleft side was measured 
to determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure 
5.3.2.1 displays the raw percent residual defect reported for the cleft side canine angulation in the 
coronal section. Even though there is a slight upward trend, this was not statistically significant. 
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When analyzing percent residual defect using a GLM following a beta distribution with logit link 
function, Table 5.3.2.1 shows that there is no statistically significant relationship between the 
percent residual defect and cleft side canine angulation in the coronal section (F=2.15; DF=1,21; 
p=0.15). 
 The regression coefficient estimates for the intercept, angulation of the canine on the cleft 
side in the coronal section, and residual variance (scale) can be viewed in Table 5.3.2.2. Note that 
these estimates are on the model scale (non-normal data distribution) and will not have a direct 
interpretation other than direction of the slope. For residual defect and angulation of the canine on 
the alveolar cleft side in the coronal section, the estimated slope is positive with a value of 
0.03561 (standard error = 0.024). 
5.3.3. Cleft side Canine Angulation; Sagittal Section 
Angulation, in the sagittal section, of the canine on the alveolar cleft side was measured 
to determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure 
5.3.3.1 displays the raw percent residual defect reported for the cleft side canine angulation in the 
sagittal section. Even though there is a slight downward trend, this was not statistically 
significant. When analyzing percent residual defect using GLM following a beta distribution with 
logit link function, Table 5.3.3.1 shows that there is no statistically significant relationship 
between the percent residual defect and angulation of the canine on the cleft side in the sagittal 
section (F=0.13; DF=1,21; p=0.72). 
 The regression coefficient estimates for the intercept, angulation of the canine on the cleft 
side in the sagittal section, and residual variance (scale) can be viewed in Table 5.3.3.2. Note that 
these estimates are on the model scale (non-normal data distribution) and will not have a direct 
interpretation other than direction of the slope. For residual defect and angulation of the canine on 
the alveolar cleft side in the sagittal section, the estimated slope is negative with a value of -
0.00592 (standard error = 0.016). 
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5.3.4. Cleft Side Canine Distance from the Occlusal Plane 
Distance of the canine on the alveolar cleft side from the occlusal plane was measured to 
determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure 5.3.4.1 
displays the raw percent residual defect reported for the cleft side canine distance from the 
occlusal plane. When analyzing percent residual defect using GLM following a beta distribution 
with logit link function, Table 5.3.4.1 shows that there is no statistically significant relationship 
between the percent residual defect and distance of the canine on the cleft side from the occlusal 
plane (F=0.11; DF=1,21; p=0.74). 
 The regression coefficient estimates for the intercept, cleft side canine distance from the 
occlusal plane, and residual variance (scale) can be viewed in Table 5.3.4.2. Note that these 
estimates are on the model scale (non-normal data distribution) and will not have a direct 
interpretation other than direction of the slope. For residual defect and distance of the canine on 
the alveolar cleft side from the occlusal plane, the estimated slope is positive with a value of 
0.01404 (standard error = 0.042). 
5.4. Volumetric Values and Percent Residual Defect 
 Volume of the clefts were measured to determine the overall success rate of using 
rhBMP-2 as a grafting material during secondary alveolar bone grafts. Pre-graft and 6-month 
post-graft CBCT images were analyzed for the 23 patients. Table 5.4.1 displays the observed cleft 
volumes (in mm3) for the subjects included in this study. Overall, the mean pre-graft volume of 
the unilateral cleft was 1026.97 (SD = 390.11) and the mean post-graft volume of the unilateral 
cleft was 333.48 (SD = 250.94). Table 5.4.1 also outlines the mean volume values for 
male/female and left/right side alveolar cleft. This information is also represented in a box & 
whisker plot with the inner quartile range displayed (Figure 5.4.1). 
 To report the success rates of secondary alveolar bone grafts, we reported our 
measurements as a percent residual defect calculated from the pre-graft and post-graft CBCT 
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scans. Overall, the mean percent residual defect was 0.32 (32%) (SD = 0.22) meaning a percent 
bone fill value of 0.68 (68%) following the procedure. These values, along with average percent 
residual defect values for male/female and left/right side alveolar clefts can be seen in Table 
5.4.2. This information is also represented in box and whisker plots with the inner quartile range 
displayed (Figures 5.4.2, 5.4.3, and 5.4.4). 
5.5. Intra-examiner and Inter-examiner Reliability 
 Intraclass correlations were used to measure intra-examiner and inter-examiner values 
throughout this study. The intraclass correlations-3 (ICC3) was the value analyzed. This value is 
used when all subjects are rated by the same raters who are assumed to be the entire population of 
raters (Shrout and Fleiss 1979). For this study, the ICC3 values ranged from 0.72 to 1.0 
representing a moderate to excellent correlation between the investigators. A general guideline 
for ICC values is: below 0.50 (poor), between 0.50 and 0.75 (moderate), between 0.75 and 0.90 
(good), and above 0.90 (excellent). 
 Table 5.5.1 displays the volumes of the unilateral alveolar clefts. 20 pre-graft and post-
graft CBCT images were analyzed by investigator LP and SP independently. The ICC3 value for 
the inter-examiner reliability for the volumes of the cleft was 0.99 (F=167; DF=19,19; p<0.0001). 
These results are represented in Table 5.5.2. 
Tables 5.5.3 and 5.5.4 display the intra-examiner results for the volumes measured (by 
investigators LP and SP) for the unilateral alveolar clefts. The ICC3 value for investigator LP was 
1.0 (F=746; DF=19,19; p<0.0001). The ICC3 value for investigator SP was also 1.0 (F=1025; 
DF=19,19; p<0.0001). 
The inter-examiner reliability for the length of the canine on the cleft side can be seen in 
Table 5.5.5. The ICC3 value for inter-examiner reliability length of the canine on the cleft side 
was 0.72 (F=6.1; DF=19,19; p<0.001). 
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Tables 5.5.6 and 5.5.7 display the intra-examiner results for the length of the canine on 
the cleft side, measured by investigators LP and SP. The ICC3 value for investigator LP was 0.94 
(F=34; DF=19,19; p<0.0001). The ICC3 value for investigator SP was 0.94 (F=32; DF=19,19; 
p<0.0001). 
Angulation, in both the coronal and sagittal sections, of the canine on the alveolar cleft 
side as well as the distance of the canine on the alveolar cleft side from the occlusal plane was 
only measured by investigator LP. Intra-examiner reliability was calculated for these values and 
can be seen in Tables 5.5.8, 5.5.9, and 5.5.10. The ICC3 value for the angulation of the canine on 
the cleft side in the coronal section was 0.95 (F=41; DF=19,19; p<0.0001). The ICC3 value for 
the angulation of the canine on the cleft side in the sagittal section was 0.99 (F=180; DF=19,19; 
p<0.0001). And finally, the ICC3 value for the distance of the canine on the cleft side from the 















Figure 5.2.1.1: Box & Whisker Plot for Male/Female. This plot represents the raw data of 
percent residual defect by male/female. Note there are not statistics being done here but it gives 











Table 5.2.1.1: Type III Tests for Fixed Effects – Male/Female. This table analyzes the percent 
residual defect by male/female using a generalized linear model following a beta distribution. A 
statistically significant difference was noticed in the true mean percent residual defect between 
males and females. 
 
 
Table 5.2.1.2: Least Squares Means – Male/Female. This table provides the least squares 
means for the mean percent residual defect by male and female. Calculations were made using 









Figure 5.2.1.2: Least Squares Means Plot for Male/Female. This plot represents the least 
squares means values in Table 5.2.1.2. The black dot corresponds to the mean estimated percent 
residual defect while the error bars correspond to the lower mean and upper mean values 
indicating a 95% confidence interval. Levels with different letters indicate a statistically 









Figure 5.2.2.1: Scatter Plot – Age of Patient at Time of Grafting. This scatter plot displays 
the raw percent residual defect by age. The ages are represented as a quantitative/numeric value. 
The blue line represents a linear regression line to provide an idea of whether we are seeing a 
trend or not. The shaded area represents the 95% confidence interval. Note there are not 













Table 5.2.2.1: Type I Tests of Fixed Effects - Age. This table analyzes the percent residual 
defect by patient age at the time of grafting by using a generalized linear model following a beta 
distribution. No statistically significant relationship between the percent residual defect and the 
age of the patient was noticed. 
 
 
Table 5.2.2.2: Regression Coefficient Estimates for Age of the Patient. This table displays the 
regression coefficient estimates for the intercept, age of the patient at the time of grafting, and 
residual variance (scale). These estimates are on a model scale so will not have a direct 











Figure 5.2.3.1: Box & Whisker Plot for Left/Right Side Alveolar Cleft. This plot represents 
the raw data of percent residual defect by left/right side alveolar cleft. Note there are not 
statistics being done here but it gives us a good idea of what we might expect. Light blue: left 
















Table 5.2.3.1: Type III Tests for Fixed Effects – Left/Right Side Alveolar Cleft. This table 
analyzes the percent residual defect by left/right side cleft using a generalized linear model 
following a beta distribution. No statistically significant difference was noticed in the true mean 
percent residual defect between left and right side alveolar clefts. 
 
 
Table 5.2.3.2: Least Squares Means – Left/Right Side Alveolar Cleft. This table provides the 
least squares means for the mean percent residual defect by left/right side cleft. Calculations 









Figure 5.2.3.2: Least Squares Means Plot for Left/Right Side Alveolar Cleft. This plot 
represents the least squares means values in Table 5.2.3.2. The black dot corresponds to the 
mean estimated percent residual defect while the error bars correspond to the lower mean and 
upper mean values indicating a 95% confidence interval. Levels with different letters indicate a 











Figure 5.3.1.1: Scatter Plot – Cleft Side Canine Root Length. This scatter plot displays the 
raw percent residual defect by cleft side canine root length (as a percentage of mature length). 
The blue line represents a linear regression line to provide an idea of whether we are seeing a 
trend or not. The shaded area represents the 95% confidence interval. Note there are not 















Table 5.3.1.1: Type I Tests of Fixed Effects – Cleft Side Canine Root Length. This table 
analyzes the percent residual defect by cleft side canine root length using a generalized linear 
model following a beta distribution. No statistically significant relationship was noticed between 
the percent residual defect and the canine root length on the alveolar cleft side. 
 
 
Table 5.3.1.2: Regression Coefficient Estimates for Cleft Side Canine Root Length. This 
table displays the regression coefficient estimates for the intercept, cleft side canine root length, 
and residual variance (scale). These estimates are on a model scale so will not have a direct 











Figure 5.3.2.1: Scatter Plot – Cleft Side Canine Angulation (Coronal). This scatter plot 
displays the raw percent residual defect by cleft side canine angulation in the coronal section. 
The blue line represents a linear regression line to provide an idea of whether we are seeing a 
trend or not. The shaded area represents the 95% confidence interval. Note there are not 














Table 5.3.2.1: Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Coronal). This 
table analyzes the percent residual defect by cleft side canine angulation in the coronal section 
using a generalized linear model following a beta distribution. No statistically significant 
relationship was noticed between the percent residual defect and the cleft side canine angulation 
when viewed in the coronal section. 
 
 
Table 5.3.2.2: Regression Coefficient Estimates for Cleft Side Canine Angulation 
(Coronal). This table displays the regression coefficient estimates for the intercept, cleft side 
canine angulation in the coronal section, and residual variance (scale). These estimates are on a 












Figure 5.3.3.1: Scatter Plot – Cleft Side Canine Angulation (Sagittal). This scatter plot 
displays the raw percent residual defect by cleft side canine angulation in the sagittal section. 
The blue line represents a linear regression line to provide an idea of whether we are seeing a 
trend or not. The shaded area represents the 95% confidence interval. Note there are not 














Table 5.3.3.1: Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Sagittal). This 
table analyzes the percent residual defect by cleft side canine angulation in the sagittal section 
using a generalized linear model following a beta distribution. No statistically significant 
relationship was noticed between the percent residual defect and the cleft side canine angulation 
when viewed in the sagittal section. 
 
 
Table 5.3.3.2: Regression Coefficient Estimates for Cleft Side Canine Angulation (Sagittal). 
This table displays the regression coefficient estimates for the intercept, cleft side canine 
angulation in the sagittal section, and residual variance (scale). These estimates are on a model 












Figure 5.3.4.1: Scatter Plot – Cleft Side Canine Distance from Occlusal Plane. This scatter 
plot displays the raw percent residual defect by cleft side canine distance from occlusal plane. 
The blue line represents a linear regression line to provide an idea of whether we are seeing a 
trend or not. The shaded area represents the 95% confidence interval. Note there are not 












Table 5.3.4.1: Type I Tests of Fixed Effects – Cleft Side Canine Distance from Occlusal 
Plane. This table analyzes the percent residual defect by cleft side canine distance from the 
occlusal plane using a generalized linear model following a beta distribution. No statistically 




Table 5.3.4.2: Regression Coefficient Estimates for Cleft Side Canine Distance from 
Occlusal Plane. This table displays the regression coefficient estimates for the intercept, cleft 
side canine distance from occlusal plane, and residual variance (scale). These estimates are on a 









Table 5.4.1: Overall Volumetric Values for Unilateral Clefts. This table displays the overall 
volumetric values in mm3 for the unilateral clefts. A total of 23 patients were included for the 
statistical analysis summary. Pre-graft and 6-month post-graft CBCT images were evaluated. 
The table also includes volumetric values for left/right alveolar cleft and male/female variables 
within our sample. 
 
 
Figure 5.4.1: Overall Volumetric Values for Unilateral Clefts. This box & whisker plots 
display the overall volumetric values in mm3 for the unilateral clefts. A total of 23 patients were 
included for the statistical analysis summary. Pre-graft (left) and 6-month post-graft (right) 
CBCT images were evaluated. Black horizontal line: 50th percentile (median) Blue box: inner 









Table 5.4.2: Percent Residual Defect Using rhBMP-2. This table shows the overall percent 
residual defect measured on the 6-month post-graft CBCT images for the 23 patients in our 
study. A mean value of 0.32 (SD = 0.22) represents a 32% residual defect in the post-graft scan 
meaning an overall bone fill of 68% using rhBMP-2 for secondary grafting of unilateral alveolar 
clefts. The table also includes the breakdown of percent residual defect for left/right alveolar 
cleft and male/female variables within our sample. 
 
 
Figure 5.4.2: Percent Residual Defect Using rhBMP-2. This box & whisker plot displays the 
overall percent residual defect using rhBMP-2. A total of 23 patients were included for the 
statistical analysis summary. Black horizontal line: 50th percentile (median) Blue box: inner 

















Figure 5.4.3: Percent Residual Defect Using rhBMP-2; Male/Female. This box & whisker 
plot displays the overall percent residual defect using rhBMP-2 for male/female patients. 11 
males (right) and 12 females (left) were included for the statistical analysis summary. Black 















Figure 5.4.4: Percent Residual Defect Using rhBMP-2; Left/Right Alveolar Cleft. This box 
& whisker plot displays the overall percent residual defect using rhBMP-2 for left/right alveolar 
clefts. 13 left alveolar clefts (left) and 10 right alveolar clefts (right) were included for the 
statistical analysis summary. Black horizontal lines: 50th percentile (median) Blue boxes: inner 








Table 5.5.1: Inter-examiner Reliability Raw Data. This table shows the volumetric values in 
mm3 for the unilateral alveolar cleft on 10 patients included in this study. The 20 CBCT images 
(both pre-graft and post-graft) were measured independently by investigators LP and SP and 
submitted for statistical analysis.  
 
 
Table 5.5.2: Inter-examiner ICC3 Results. This table displays the inter-examiner intraclass 
correlation coefficients (ICC3) for unilateral cleft volume measured by investigators LP and SP. 
The results are based on 20 independently measured CBCT images. An ICC3 value of 0.99 







Table 5.5.3: Intra-examiner ICC3 Results for Cleft Volume; Investigator LP. This table 
displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft volume. The 
results are based on initial 20 CBCT images measured by investigator LP. After at least 2 weeks, 
these same 10 patients (20 CBCT images) were analyzed by investigator LP. An ICC3 value of 
1.0 represents excellent correlation. 
 
 
Table 5.5.4: Intra-examiner ICC3 Results for Cleft Volume; Investigator SP. This table 
displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft volume. The 
results are based on initial 20 CBCT images measured by investigator SP. After at least 2 weeks, 
these same 10 patients (20 CBCT images) were analyzed by investigator SP. An ICC3 value of 
1.0 represents excellent correlation. 
 
 
Table 5.5.5: Inter-examiner ICC3 Results for Cleft Side Canine Length. This table displays 
the inter-examiner intraclass correlation coefficients (ICC3) for cleft side canine length 
measured by investigators LP and SP. The results are based on 20 independently measured 







Table 5.5.6: Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator LP. 
This table displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft side 
canine length. The results are based on initial 20 CBCT images measured by investigator LP. 
After at least 2 weeks, these same 10 patients (20 CBCT images) were analyzed by investigator 
LP. An ICC3 value of 0.94 represents excellent correlation. 
 
 
Table 5.5.7: Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator SP. 
This table displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft side 
canine length. The results are based on initial 20 CBCT images measured by investigator SP. 
After at least 2 weeks, these same 10 patients (20 CBCT images) were analyzed by investigator 
SP. An ICC3 value of 0.94 represents excellent correlation. 
 
 
Table 5.5.8: Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Coronal); 
Investigator LP. This table displays the intra-examiner intraclass correlation coefficients (ICC3) 
for cleft side canine angulation in the coronal section. The results are based on initial 20 CBCT 
images measured by investigator LP. After at least 2 weeks, these same 10 patients (20 CBCT 














Table 5.5.9: Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Sagittal); 
Investigator LP. This table displays the intra-examiner intraclass correlation coefficients (ICC3) 
for cleft side canine angulation in the sagittal section. The results are based on initial 20 CBCT 
images measured by investigator LP. After at least 2 weeks, these same 10 patients (20 CBCT 




Table 5.5.10: Intra-examiner ICC3 Results for Cleft Side Canine Distance from Occlusal 
Plane; Investigator LP. This table displays the intra-examiner intraclass correlation coefficients 
(ICC3) for cleft side canine distance from the occlusal plane. The results are based on initial 20 
CBCT images measured by investigator LP. After at least 2 weeks, these same 10 patients (20 





CHAPTER 6: DISCUSSION 
6.1. Demographic Variables and Their Effects on Outcomes 
 6.1.1. Gender 
 There was a statistically significant difference in the volume of the residual defect 
between males and females (F=10.63; DF=1,21; p=0.0037) in our study. The estimated mean 
percent residual defect for females was 20.52% (Standard Error = 4.2%) and we are 95% 
confident the true mean percent residual defect for females is between 13.1% and 30.68%. The 
estimated mean percent residual defect for males was 44.20% (Standard Error = 5.7%) and we are 
95% confident the true mean percent residual defect for males is between 32.93% and 56.1% 
(Figure 5.2.1.2). These values were compared to and noticeably different than a study by Saruhan 
and Ertas in 2017. This study used anterior iliac crest as the grafting material for unilateral and 
bilateral alveolar clefts. They concluded a mean bone fill of 68.23% +/- 9.43% for females and 
63.09% +/- 10.72% for males. There was no statistically significant difference found between 
males and females in this study (Saruhan and Ertaş 2017). 
 It is not likely that a different grafting material, such as rhBMP-2, would cause gender 
differences to have an effect on alveolar cleft graft outcomes. 
 6.1.2. Age of the Patient at the Time of Grafting 
 There was no statistically significant relationship between the percent residual defect and 
the age of the patient at the time of grafting (F=0.00; DF=1,21; p=0.97). The effect of age on the 
outcomes of the alveolar bone grafts was calculated as a quantitative/numeric value as well as a 
qualitative/categorical value. The quantitative/numeric values were reported in our study. Since 
the data was on the model scale (non-normal data distribution), a direct interpretation could not 
be determined. However, the direction of the slope value provided insight on how age of the 
patient at the time of grafting could affect the outcome. The slope value for age and percent 
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residual defect was -0.00466 and can be seen in Table 5.2.2.2. This negative slope relationship 
suggests that as age increased within our inclusion criteria range, the percent residual defect 
decreased and hence bone fill increased. 
 A systematic review of the literature was completed in 2018 by Kaura et al. to understand 
how age effects the outcomes of alveolar grafts. When looking at the studies that used 
chronological age as the determining factor, the authors found the chronological age for alveolar 
grafting ranged from 10-14 with an average of 10 years old. Our results are similar to the 
conclusion of this 2018 study; bone grafting completed at an earlier chronologic age did not show 
better outcomes (Kaura et al. 2018). 
 6.1.3. Side of the Alveolar Cleft 
 There was no statistically significant difference in the true mean percent residual defect 
between left and right side alveolar clefts (F=0.6; DF=1,21; p=0.45). The estimated mean percent 
residual defect for the left side alveolar cleft was 34.46% (Standard Error = 5.7%) and we are 
95% confident the true mean percent residual defect for left side alveolar cleft is between 23.67% 
and 47.12%. The estimated mean percent residual defect for the right side alveolar cleft was 
28.06% (Standard Error = 6.0%) and we are 95% confident the true mean percent residual defect 
for right side alveolar cleft is between 17.31% and 42.08% (Figure 5.2.3.2).   
 There is very limited research available on whether the affected side of the patient with 
unilateral alveolar cleft has an effect on the graft success rate. Our study analyzed this 
comparison and found no statistically significant difference. 
6.2. Linear Values and Their Effects on Outcomes 
 6.2.1. Cleft Side Canine Root Length 
There was no statistically significant relationship between the percent residual defect and 
length of the canine on the alveolar cleft side (F=0.61; DF=1,21; p=0.44). Since the data was on 
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the model scale (non-normal data distribution), a direct interpretation could not be determined. 
However, the direction of the slope value provided insight on how the cleft side canine root 
length could affect the outcome. The slope value for cleft side canine root length was -0.9491 and 
can be seen in Table 5.3.1.2. This negative slope relationship suggests that as the length of the 
canine on the cleft side increased, the percent residual defect decreased and hence bone fill 
increased. 
 The overall consensus is that outcomes are better when secondary alveolar bone grafts 
are completed based on the dental age or root development of the canine on the cleft side. The 
ideal time for alveolar grafting procedures to be completed is before the eruption of the cleft side 
canine and when the root of this tooth has one-half to two-thirds of its root development 
completed (Bergland et al. 1986; Boyne and Sands 1972). In our study, we could not demonstrate 
a statistically significant difference when analyzing the length of the canine on the cleft side.  
6.2.2. Cleft Side Canine Angulation; Coronal and Sagittal Sections 
There was no statistically significant relationship between the percent residual defect and 
the angulation of the canine on the cleft side in neither the coronal section (F=2.15; DF=1,21; 
p=0.15) nor the sagittal section (F=0.13; DF=1,21; p=0.72). Since the data was on the model 
scale (non-normal data distribution), a direct interpretation could not be determined. However, 
the direction of the slope value provided insight on how the angulation of the canine on the cleft 
side in both the coronal and sagittal sections could affect the outcome. The slope value for the 
cleft side canine angulation in the coronal section was 0.03561 and can be seen in Table 5.3.2.2. 
This positive slope relationship suggests that as the angulation, in the coronal section, of the 
canine on the cleft side increased, the percent residual defect also increased and hence bone fill 
decreased. The slope value for the angulation of the canine on the cleft side in the sagittal section 
was -0.00592 and can be seen in Table 5.3.3.2. This negative slope relationship suggests that as 
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the angulation, in the sagittal section, of the canine on the cleft side increased, the percent 
residual defect decreased and hence bone fill increased. 
Most of the previous studies relating to this variable focuses on the natural eruption of the 
canine following the secondary alveolar grafting procedure. Vellone et al. studied the effects of 
secondary alveolar bone grafting on canine eruption. The authors concluded there was no proof 
that inclination of the canine influenced the eruption before and after the grafting procedure. They 
did however, conclude secondary alveolar bone grafts significantly affected the natural eruption 
process of the canine (Vellone et al. 2017). Although this study did not draw a correlation 
between inclination of the canine and its eruption process, we wanted to understand the effect of 
canine inclination on overall success rates for unilateral alveolar grafts. It appears that the more 
upright the permanent canine on the cleft side is, in both sections, at the time of grafting, the 
higher percentage of bone fill recorded. Still, no statistically significant difference was noticed.  
 6.2.3. Cleft Side Canine Distance from the Occlusal Plane 
There was no statistically significant relationship between the percent residual defect and 
the distance of the canine on the alveolar cleft side from the occlusal plane (F=0.11; DF=1,21; 
p=0.74). Since the data was on the model scale (non-normal data distribution), a direct 
interpretation could not be determined. However, the direction of the slope value provided insight 
on how the distance of the canine on the cleft side from the occlusal plane could affect the 
outcome. The slope value for the distance of the canine on the cleft side from the occlusal plane 
was 0.01404 and can be seen in Table 5.3.4.2. This positive slope relationship suggests that as 
this distance from the occlusal plane increased, the percent residual defect also increased and 
hence bone fill decreased. 
Our results are similar to those of Upadya et al.  This study concluded that the position of 
the canine on the cleft side, inclination, and distance from the cleft itself, did not have an effect 
on the success rates of secondary alveolar grafts (Upadya et al. 2013). However, it is still 
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important to consider the positive slope relationship. It seems as though secondary alveolar grafts 
can indeed be completed too early in the patients’ lives.   
6.3. Volumetric Values and Percent Residual Defect 
 Out of the 24 patients analyzed, one patient was excluded during the statistical analysis 
with a failed alveolar graft. Data from 23 patients were evaluated for success rates. rhBMP-2 was 
used for all of the unilateral alveolar cleft grafting procedures completed at the University of 
Nebraska Medical Center Oral and Maxillofacial Surgery Center. The mean volume of the pre-
graft unilateral cleft was 1026.97mm3 (SD = 390.11) and the mean volume of the post-graft 
unilateral cleft was 333.48mm3 (SD = 250.94). These volumes can be seen in Table 5.4.1. The 
overall average percent residual defect at 6-months post-graft was 0.32 (32%) with a standard 
deviation of 0.32 (32%). This corresponds to an overall average bone fill of 0.68 (68%) with a 
standard deviation of 0.22 (22%). These values can be seen in Table 5.4.2. 
 Our results on the outcomes of secondary grafting unilateral alveolar clefts seem to be 
slightly lower than previous literature reports. The study by Francis et al. used occlusal 
radiographs to compare rhBMP-2 and iliac crest as grafting materials. The success rates were 
97.2% and 84.2% for rhBMP-2 and iliac crest respectively (Francis et al. 2013). The difference in 
understanding the pyramid-shaped cleft defect between occlusal radiographs and CBCT images 
may lead to this difference in results. The 2-dimensional images may overestimate the success 
rates. Linderup et al. concluded a pre-graft cleft volume of 934mm3 with an average percentage 
bone fill of 87%. This study used mandibular symphyseal bone as the grafting material of choice 
and analyzed the outcomes with CBCT images (Linderup et al. 2016). Oberoi et al. studied the 
outcomes of secondary bone grafts of alveolar clefts using CBCT images and found an average 
bone fill of 84% (Oberoi et al. 2009). And finally, a study conducted by Herford et al. specifically 
focused on the outcomes of repairing the premaxillary cleft using rhBMP-2 and evaluated with 
CT images found a mean bone fill of 71.7% at 4-months post-graft (Herford et al. 2007). 
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 All of the previous studies mentioned have either used 2-dimensional radiographs to 
assess a 3-dimensional defect, included unilateral and bilateral alveolar clefts, and/or used a 
different material to complete the graft procedure. It is important to understand our results using 
rhBMP-2 to graft unilateral alveolar clefts and evaluating the outcomes using CBCT images. Our 
results on percent residual defect/percent bone fill are similar to the results reported by Herford et 
al., which closely resembles our study parameters.   
6.4. Limitations of the Study 
6.4.1. Radiographic Limitations 
A limitation of this study is in relation to the method of radiographic capturing, CBCT 
images. It is well known that CBCT is a reliable tool for orthodontic treatment as well as research 
modalities (Kapila et al. 2011). However, problems arise when attempting to accurately measure 
hard tissues, such as the borders of the alveolar cleft defect (Molen 2010). The technology used in 
this study offers a diagnostic value of 0.2 mm voxels. Theoretically, this means we could measure 
up to 0.2 mm and be fairly confident at that level. However, previous literature demonstrates that 
the actual spatial resolution is worse than the true voxel size with factors such as noise and 
artifact negatively affect the quality of the image (Molen 2010). The spatial resolution used 
within this study is not entirely known, but past studies of older CBCT images correlated a 0.3 
mm voxel size to a spatial resolution around 0.6 mm (Brullmann and Schulze 2015). When trying 
to understand the amount of percent residual defect or bone fill in the alveolar cleft area, it is 
important to understand the actual magnitudes of change and assess if they accurately can be 
measured or assessed based off the voxel size, or more importantly, the true spatial resolution. 
CBCT image quality was also a limitation that was noticed during data collection. 
Medical records and pre-graft/post-graft CBCT images of all patients who received secondary 
alveolar bone grafts between June 1, 2014 and January 1, 2020 were retrieved. Of the 55 patients 
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that met our initial criteria, only 24 patients had pre-graft and post-graft CBCT images that were 
free of noise or artifact. 
6.4.2. Software Limitations 
The ITK-SNAP 3.8.0 software used for segmentation introduced other limitations to our 
study. The degree of image quality and pixelation provided by the software determines the 
accuracy of measurements. This limitation was observed during the volumetric data gathering 
process for our unilateral cleft defects. Volumetric segmentation introduced challenges in 
obtaining a clear distinction between similar grey scale pixels such as those of alveolar bone and 
grafting material. To overcome these inaccuracies, the volumetric thresholding parameters were 
set very similar, within ITK-SNAP 3.8.0, when measuring the same patient. Additionally, strict 
semi-automatic and manual segmentation parameters were developed between the two 
investigators (LP and SP).  
The anterior and posterior borders of the alveolar cleft were determined by manual 
segmentation. The contralateral normal anatomical bone structure was mimicked to define these 
borders. The two investigators (LP and SP) were standardized and calibrated before segmentation 
to eliminate as much subjectivity as possible. Intraclass correlations for inter- and intra-examiner 
reliability were calculated to determine the accuracy of our measurements. However, this is 
inevitably a limitation within segmentation studies and has to be mentioned. 
Lastly, percent residual defect was reported as our outcome measure to help eliminate the 
variability within the reported volumetric ranges. This limitation will exist in segmentation 
research studies until new software updates become available to provide more accurate 





6.4.3. Sample Limitations  
Drawing a correlation between our 23 patients included for statistical analysis to the true 
population is another limitation. Our patients were only sampled from one location, University of 
Nebraska Medical Center Oral and Maxillofacial Surgery Center. The demographics may not 
represent the entire population.  
Other sample limitations were noted within our study. First, narrowing down patients for 
our study was dependent on the notes, CBCT images, and histories provided by the oral surgeon 
at the location mentioned above. We tried to minimize the amount of variability in patient 
selection by defining specific inclusion and exclusion criteria. Next, true randomization is 
impossible with the nature of retrospective studies. We attempted to minimize the potential bias 
during data collection and measurements. Patient records were collected with the specified 
inclusion and exclusion criteria to reduce bias. Additionally, the 23 patients measured in this 
study were randomly split up into two groups for the investigators (LP and SP) to segment within 
ITK-SNAP 3.8.0. 
6.5. Conclusions 
 The present study indicates a statistically significant difference in the percent residual 
defect exists between males and females. This was the only variable analyzed in this study that 
demonstrated a significant difference. There was not enough evidence to conclude there is a 
significant difference in the percent residual defect between left and right side alveolar clefts. 
Additionally, our data did not demonstrate a significant relationship between the percent residual 
defect and the following variables: age of the patient at the time of surgery, cleft side canine root 
length, cleft side canine angulation in the coronal section, cleft side canine angulation in the 
sagittal section, or cleft side canine distance from the occlusal plane. 
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 Correlation was determined for several of the variables studied. Although not statistically 
significant, these correlates could provide insight into the relationship that exists between the 
outcomes of secondary alveolar bone grafts and the variables studied. 
 The present study also suggests that rhBMP-2 could be an alternative grafting material to 
anterior iliac crest. With percent residual defect values of 32% and bone fill values of 68% six 
months following surgery, rhBMP-2 seems to demonstrate similar results compared to other 
grafting materials. This could allow patients to choose this alternate material to eliminate the 
complications associated with harvesting anterior iliac crest bone while still achieving successful 
outcomes.   
6.6. Future Research 
 Future research for this area could address some of the limitations of the present study. 
The CBCT imaging parameters could be improved to more accurately provide us with the data 
necessary for research. Spatial resolution and volume rendering software need improvement to 
allow for more efficient segmentation and to obtain more accurate volumetric data for analysis. 
Manual segmentation is currently needed during volumetric measurements to distinguish between 
similar density areas such as alveolar bone and grafting material. The method of calculating a 
percent residual defect has allowed projects to minimize this effect, but intensive labor is required 
for manual segmentation. Superior volume segmentation software exists, however most have 
algorithms that are not verified or standardized. Future studies that use segmentation software that 
clearly and accurately auto-segments the area of interest would allow for more accurate 
volumetric parameters and assessments while eliminating the need for tedious manual 
segmentation. 
 Our study was retrospective in design with well-defined inclusion and exclusion criteria. 
Future prospective studies in which records are taken during diagnosis and treatment could 
provide valuable information. Pre-treatment risk factors could be accounted for if the treatment 
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protocols were standardized and clinical records were maintained throughout treatment. 
Additionally, patient demographics and clinical information such as unilateral or bilateral alveolar 
cleft, age of the patient, and side of the alveolar cleft could be assessed for treatment 
standardization. 
 Finally, a prospective study to compare the outcomes of rhBMP-2 and anterior iliac crest 
for secondary alveolar bone grafts in unilateral alveolar cleft patients would provide more insight 
into the effectiveness of this alternative material. A larger sample size, increased variety of 
patient demographics, and including multiple surgical sites/surgeons may lead to more reliable 
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